Follow The Filings

ZBH Zimmer Biomet

Health Care, filed as ZIMMER BIOMET HOLDINGS INC (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 2

  • 1 Owner
  • #121
  • Max 0.0%
  • Master 0.19%
  • $68K

Who owns this now

Largest portfolio weights among holders, up to 0.0% (Kentucky Trust Co., Kentucky Trust). Not free-float ownership.

  1. Kentucky Trust Co. 0.03%

Who owns ZBH

Sorted by value, long equity only, as of 2026 Q3.

History
Kentucky Trust Co., Kentucky Trust 0.03% Hold 770 $68K History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by ZBH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ZBH insider trades
  • None no insider bought on the open market
  • $1.6M sold by 4 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Kevin R Thornal Grp Pres-Global Business
    Sale
    $529K 5,691 shares at $92.95 100% of stake
    Traded Sep 11 Filed Sep 15
    ↗
  2. Chad F Phipps See remarks below.
    Sale
    $295K 3,000 shares at $98.35 4.4% of stake
    Traded Sep 4 Filed Sep 9
    ↗
  3. Sang Yi Group President, Asia Pacific
    Sale
    $413K 5,000 shares at $82.64 16% of stake
    Traded May 29 Filed Jun 2
    ↗
  4. Lori Winkler SVP and CHRO
    Sale
    $251K 2,650 shares at $94.66 21% of stake
    Traded Mar 12 Filed Mar 16
    ↗
  5. Sang Yi Group President, Asia Pacific
    Sale
    $96K 1,000 shares at $96.49 5.4% of stake
    Traded Feb 12 Filed Feb 17
    ↗

Also filed in the last 12 months, not counted as buying or selling: 36 option exercises and 32 share withholdings for taxes.

Congress

3 members of Congress traded ZBH in the last three years: 2 buys and 2 sales. 1 member listed it in 2025 annual reports.

All Congress trades
  1. Alan Armstrong R-OK Buy $1K–$15K Mar 27 filed Jul 21
  2. Robert P. Bresnahan, Jr. R-PA-8 Sell $1K–$15K May 15, 2025 filed May 31, 2025
  3. Robert P. Bresnahan, Jr. R-PA-8 Buy $1K–$15K Apr 8, 2025 filed May 8, 2025
  4. Julie Johnson D-TX-32Joint Sell $1K–$15K Feb 11, 2025 filed Mar 12, 2025

SEC filings

Recent issuer filings from EDGAR, 10 shown.

Filed Form Detail Links
8-K 5.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01,1.02,2.03,9.01 Filing Doc
8-K 5.07,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 12 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $7.39B $7.68B $8.23B
Gross profit * $5.31B $5.49B $5.74B
Gross margin * 71.8% 71.5% 69.7%
Net income $1.02B $0.904B $0.705B
Net margin * 13.8% 11.8% 8.6%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $4.61B $4.67B $5.12B
Total non-current assets * $16.89B $16.69B $17.97B
Total assets $21.5B $21.37B $23.09B
Total current liabilities $2.86B $2.45B $2.58B
Total non-current liabilities * $6.15B $6.44B $7.8B
Total equity $12.48B $12.47B $12.7B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations — — $1.7B
Cash from investing — — -$1.98B
Cash from financing — — $326M
Net change in cash $40.1M $109.7M $66.4M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.